Figure 1.
Effect of the p38 MAPK inhibitor SB202190 on expression of p-p38 MAPK in the hippocampus of a vascular dementia (VaD) rat model. Expression of p-p38 MAPK was determined by Western blot and protein expression normalized to β-actin. The data are expressed as means ± standard deviation (SD) (n = 6); **P < 0.01 versus sham-operated group, ## P < 0.01 SB202190 group versus model group.